EU greenlights Medtronic's aortic valve delivery system

The European Union (EU) has granted Medtronic a CE mark for its CoreValve delivery system with AccuTrak Stability layer, which is used during transcatheter aortic valve implantation (TAVI).

According to Minneapolis-based Medtronic, the AccuTrak technology facilitates control and accuracy during the deployment of the CoreValve device. The CoreValve system was indicated to treat patients with severe aortic valve stenosis without open-heart surgery and gained a CE mark in March 2007.

Currently, neither the CoreValve nor the AccuTrak system are approved for use in the U.S.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.